Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02217410
What this trial is testing

CCFZ533X2201 - PoC Study in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 59
Early research (Phase 1)Study completedNCT05862974
What this trial is testing

A Dose-escalation Study of LPM3480392 in Chinese Healthy Subjects

Who this might be right for
Healthy
Luye Pharma Group Ltd. 80
Early research (Phase 1)Study completedNCT03038113
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Hoffmann-La Roche 119
Early research (Phase 1)Study completedNCT02989389
What this trial is testing

LY3323795 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 42
Early research (Phase 1)Ended earlyNCT05039710
What this trial is testing

JNJ-75220795 in Japanese Participants

Who this might be right for
Fatty Liver
Janssen Pharmaceutical K.K. 9
Testing effectiveness (Phase 2)Looking for participantsNCT07498725
What this trial is testing

Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors

Who this might be right for
Neoplasms
LARKSPUR BIOSCIENCES, INC. 120
Early research (Phase 1)Looking for participantsNCT07295717
What this trial is testing

Evaluate ALN-4285 in Adult Healthy Volunteers

Who this might be right for
Healthy Volunteers
Alnylam Pharmaceuticals 76
Early research (Phase 1)Study completedNCT02573155
What this trial is testing

Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects

Who this might be right for
Asthma (Part 1)COPD (Part 2)
AstraZeneca 134
Testing effectiveness (Phase 2)Ended earlyNCT04157517
What this trial is testing

Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
NeoplasmsMelanoma
Teva Branded Pharmaceutical Products R&D LLC 45
Early research (Phase 1)Looking for participantsNCT07219589
What this trial is testing

A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

Who this might be right for
ObesityObese
Hanmi Pharmaceutical Company Limited 90
Early research (Phase 1)Study completedNCT00741689
What this trial is testing

Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy Volunteers

Who this might be right for
Healthy Volunteers
AstraZeneca 36
Early research (Phase 1)Not Yet RecruitingNCT07785193
What this trial is testing

Subcutaneous FL115 Monotherapy in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumours
Suzhou Forlong Biotechnology Co., Ltd 29
Early research (Phase 1)Study completedNCT04475848
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants

Who this might be right for
Autistic DisorderAutism Spectrum DisorderChild Development Disorders, Pervasive+2 more
Hoffmann-La Roche 88
Early research (Phase 1)Study completedNCT05807490
What this trial is testing

Learn How Different Amounts of the Study Medicine Called PF-07328948 Are Tolerated and Act in the Body in Healthy Adults

Who this might be right for
Healthy
Pfizer 86
Testing effectiveness (Phase 2)Study completedNCT01021553
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation

Who this might be right for
Premature Ejaculation
GlaxoSmithKline 77
Early research (Phase 1)Ended earlyNCT01077531
What this trial is testing

Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT02280434
What this trial is testing

Phase 1 Study Accessing the Safety and Tolerability of CBP-307

Who this might be right for
Autoimmune Diseases
Connect Biopharm LLC 64
Early research (Phase 1)Study completedNCT05287399
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Ascletis Pharmaceuticals Co., Ltd. 18
Early research (Phase 1)Looking for participantsNCT07416552
What this trial is testing

Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Hoffmann-La Roche 180
Testing effectiveness (Phase 2)Looking for participantsNCT07563738
What this trial is testing

A 2-part Phase 1/2 Open-label Trial on ODM-212

Who this might be right for
MesotheliomaPancreatic CancerNSCLC (Advanced Non-small Cell Lung Cancer)
Orion Corporation, Orion Pharma 229
Next Page